Join
Live feed
·
PRReleasevia Quantisnow
Veracyte Inc. logo

Veracyte Acquires Convergent Genomics, Expanding its Urology Diagnostics Portfolio with a Urinary Tumor DNA Testing Platform

ByQuantisnow·Wall Street's wire, on your screen.
VCYT· Veracyte Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VCYT (Veracyte Inc.) and more on Quantisnow.